27
Nov
Remedium Lifecare Limited today announced strong financial results for the quarter and half-year ended September 30, 2025, with profit after tax (PAT) nearly doubling to ₹862.34 lakh, up 85.5% from ₹464.88 lakh in Q1 FY26. EBITDA for the quarter rose 82.7% to ₹1,043.69 lakh, reflecting robust operational momentum. For the half-year, PAT surged to ₹1,327.22 lakh against ₹213 lakh in FY24-25, while consolidated revenue from operations reached ₹22,442.39 lakh. Earnings per share stood at ₹0.10 for the quarter and ₹0.15 for the half-year. Commenting on the results, Whole-Time Director Adarsh Munjal highlighted the company’s operational discipline and portfolio strength, noting…
